Insider Trading disclosures for Opus Genetics Inc.

The latest disclosure was made by Joseph K. Schachle in Opus Genetics Inc. where a trade of 52,500 Employee Stock Option (right to buy) done was reported to US exchanges on March 13, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Joseph K. Schachle	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2025	52,500	52,500	-		-	Employee Stock Option (right to buy)
Joseph K. Schachle	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2025	52,500	54,500	-		0	Common Stock
Bernhard Hoffmann	SVP of Corp. Dev.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2025	29,500	185,446	-		0	Common Stock
Bernhard Hoffmann	SVP of Corp. Dev.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2025	29,500	29,500	-		-	Employee Stock Option (right to buy)
Rabourn Amy Zaremba	SVP of Finance	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2025	39,500	39,500	-		-	Employee Stock Option (right to buy)
Rabourn Amy Zaremba	SVP of Finance	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2025	39,500	113,968	-		0	Common Stock
Nirav Jhaveri	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2025	52,500	194,293	-		0	Common Stock
Nirav Jhaveri	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2025	52,500	52,500	-		-	Employee Stock Option (right to buy)
George Magrath	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2025	330,697	330,697	-		-	Employee Stock Option (right to buy)
George Magrath	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2025	330,697	929,847	-		0	Common Stock
Ashwath Jayagopal	Chief Scientific & Dev. Ofc.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2025	52,500	125,807	-		0	Common Stock
Ashwath Jayagopal	Chief Scientific & Dev. Ofc.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Mar 2025	52,500	52,500	-		-	Employee Stock Option (right to buy)
Nirav Jhaveri	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.15 per share.	13 Feb 2025	8,207	141,793	-	1.1	9,438	Common Stock
Ashwath Jayagopal	Chief Scientific & Dev. Ofc.	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.15 per share.	13 Feb 2025	5,193	73,307	-	1.2	5,972	Common Stock
Bernhard Hoffmann	SVP of Corp. Dev.	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share.	04 Feb 2025	6,751	155,946	-	1.1	7,696	Common Stock
Rabourn Amy Zaremba	SVP of Finance	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share.	04 Feb 2025	8,190	74,468	-	1.1	9,337	Common Stock
James S.J. Manuso	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	50,222	182,259	-		-	Common Stock
Jean Bennett	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	34,021	134,021	-		-	Common Stock
George Magrath	Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.98 per share.	26 Dec 2024	100,000	599,150	-	1.0	97,600	Common Stock
George Magrath	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Dec 2024	6,200	499,150	-		0	Common Stock
Benjamin R. Yerxa	Director, President	Purchase of securities on an exchange or from another person at price $ 0.98 per share.	21 Nov 2024	10,000	342,800	-	1.0	9,834	Common Stock
George Magrath	Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 1.02 per share.	15 Nov 2024	9,706	492,950	-	1.0	9,943	Common Stock
George Magrath	Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 1.01 per share.	15 Nov 2024	90,294	483,244	-	1.0	91,215	Common Stock
Benjamin R. Yerxa	Director, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Nov 2024	332,800	332,800	-		0	Common Stock
George Magrath	Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.18 per share.	01 Nov 2024	37,050	392,950	-	1.2	43,719	Common Stock
Adrienne L. Graves	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Oct 2024	172,874	172,874	-		-	Stock Option (right to buy)
Jean Bennett	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Oct 2024	100,000	100,000	-		0	Common Stock
Jean Bennett	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Oct 2024	172,874	172,874	-		-	Stock Option (right to buy)
James S.J. Manuso	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2024	35,181	35,181	-		-	Stock Option (Right to Buy)
James S.J. Manuso	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2024	41,143	132,037	-		0	Common Stock
Richard J. Rodgers	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2024	35,181	35,181	-		-	Stock Option (Right to Buy)
Richard J. Rodgers	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2024	41,143	239,151	-		0	Common Stock
Cam S. Gallagher	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2024	41,143	77,047	-		0	Common Stock
Cam S. Gallagher	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2024	35,181	35,181	-		-	Stock Option (Right to Buy)
Sean Ainsworth	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2024	41,143	88,358	-		0	Common Stock
Sean Ainsworth	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2024	35,181	35,181	-		-	Stock Option (Right to Buy)
Susan K. Benton	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2024	35,181	35,181	-		-	Stock Option (Right to Buy)
Susan K. Benton	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2024	41,143	140,023	-		0	Common Stock
Jay Pepose	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2024	41,143	180,458	-		0	Common Stock
Jay Pepose	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2024	35,181	35,181	-		-	Stock Option (Right to Buy)
Ashwath Jayagopal	Chief Scientific & Dev. Ofc.	Purchase of securities on an exchange or from another person at price $ 1.77 per share.	22 May 2024	3,500	78,500	-	1.8	6,178	Common Stock
George Magrath	Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 1.75 per share.	17 May 2024	5,000	430,000	-	1.8	8,773	Common Stock
Jay Pepose	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Apr 2024	48,000	48,000	-		-	Stock Option (right to buy)
Jay Pepose	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Apr 2024	32,000	139,315	-		0	Common Stock
Joseph K. Schachle	Chief Operating Officer	Purchase of securities on an exchange or from another person at price $ 2.05 per share.	21 Mar 2024	2,000	2,000	-	2.1	4,100	Common Stock
Nirav Jhaveri	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 2.10 per share.	21 Mar 2024	10,000	150,000	-	2.1	21,000	Common Stock
George Magrath	Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 1.96 per share.	18 Mar 2024	25,000	425,000	-	2.0	49,050	Common Stock
Nirav Jhaveri	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2024	210,000	210,000	-		-	Employee Stock Option (right to buy)
Nirav Jhaveri	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2024	140,000	140,000	-		0	Common Stock
Jayagopal Ashwath	Chief Scientific & Dev. Ofc.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2024	75,000	75,000	-		0	Common Stock

Showing 1 to 50 of 168 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

52.56% Fall from 52W High

High volume+gain today

Insider Trading disclosures for Opus Genetics Inc.

The latest disclosure was made by Joseph K. Schachle in Opus Genetics Inc. where a trade of 52,500 Employee Stock Option (right to buy) done was reported to US exchanges on March 13, 2025.

Screeners based on Insider Trading and SAST parameters